I-Mab Biopharma
IMAB
#9469
Rank
S$74.56 M
Marketcap
$0.91
Share price
-6.87%
Change (1 day)
-62.95%
Change (1 year)

I-Mab Biopharma (IMAB) - Total debt

Total debt on the balance sheet as of September 2024 : S$5.08 Million

According to I-Mab Biopharma's latest financial reports the company's total debt is S$5.08 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

I-Mab Biopharma - Total debt on balance sheet (from 2024 to 2023)

Total debt by year

Year Total debt Change
2023-12-31S$3.52 M67.02%
2022-12-31S$2.11 M-43.56%
2021-12-31S$3.74 M786.49%
2020-12-31S$0.42 M-88.45%
2019-12-31S$3.65 M-13.92%
2018-12-31S$4.24 M-36.7%
2017-12-31S$6.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.67 B 13,241.55%๐Ÿ‡บ๐Ÿ‡ธ USA